New test could flag which men need aggressive prostate cancer treatment and which don't
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.
FOX News
Full text, translation and AI summary — after signing in
- The full article in your language
- AI summary and translation from the original
- The same account works in the Suviy app
Related coverage
Comments
Sign in to join the conversation. Sign in
No comments yet.